Literature DB >> 32015977

Liver impairment in critical illness and sepsis: the dawn of new biomarkers?

Martin Kluge1, Frank Tacke1.   

Abstract

Entities:  

Year:  2019        PMID： 32015977      PMCID： PMC6976419          DOI： 10.21037/atm.2019.12.79

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  25 in total

Review 1.  Sepsis and cholestasis.

Authors:  Richard H Moseley
Journal:  Clin Liver Dis       Date:  2004-02       Impact factor: 6.126

2.  Hyaluronic Acid Is a Biomarker for Allograft Dysfunction and Predicts 1-Year Graft Loss After Liver Transplantation.

Authors:  A A Rostved; S R Ostrowski; L Peters; J D Lundgren; J Hillingsø; P I Johansson; A Rasmussen
Journal:  Transplant Proc       Date:  2018-09-11       Impact factor: 1.066

3.  Ito cell contraction in response to endothelin-1 and substance P.

Authors:  M Sakamoto; T Ueno; M Kin; H Ohira; T Torimura; S Inuzuka; M Sata; K Tanikawa
Journal:  Hepatology       Date:  1993-10       Impact factor: 17.425

Review 4.  Cholestatic liver (dys)function during sepsis and other critical illnesses.

Authors:  Marc Jenniskens; Lies Langouche; Yoo-Mee Vanwijngaerden; Dieter Mesotten; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2015-09-21       Impact factor: 17.440

Review 5.  Hyaluronic acid as a non-invasive biomarker of liver fibrosis.

Authors:  Manuela G Neuman; Lawrence B Cohen; Radu M Nanau
Journal:  Clin Biochem       Date:  2015-07-17       Impact factor: 3.281

6.  Index serum hyaluronic acid independently and accurately predicts mortality in patients with liver disease.

Authors:  N Plevris; R Sinha; A W Hay; N McDonald; J N Plevris; P C Hayes
Journal:  Aliment Pharmacol Ther       Date:  2018-07-04       Impact factor: 8.171

7.  Jaundice in critical illness: promoting factors of a concealed reality.

Authors:  Nicola Brienza; Lidia Dalfino; Gilda Cinnella; Caterina Diele; Francesco Bruno; Tommaso Fiore
Journal:  Intensive Care Med       Date:  2006-02-01       Impact factor: 17.440

Review 8.  Immune surveillance by the liver.

Authors:  Craig N Jenne; Paul Kubes
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

9.  Liver Fibrosis Markers Improve Prediction of Outcome in Non-Acetaminophen-Associated Acute Liver Failure.

Authors:  Aya Ugamura; Po-Sung Chu; Nobuhiro Nakamoto; Nobuhito Taniki; Keisuke Ojiro; Taizo Hibi; Masahiro Shinoda; Hideaki Obara; Yohei Masugi; Akihiro Yamaguchi; Shunsuke Shiba; Rei Morikawa; Shingo Usui; Hirotoshi Ebinuma; Yuko Kitagawa; Hidetsugu Saito; Takanori Kanai
Journal:  Hepatol Commun       Date:  2018-09-21

Review 10.  Clinical review: The liver in sepsis.

Authors:  Nicolas Nesseler; Yoann Launey; Caroline Aninat; Fabrice Morel; Yannick Mallédant; Philippe Seguin
Journal:  Crit Care       Date:  2012-10-30       Impact factor: 9.097
View more
  2 in total

1.  International Normalized Ratio to Albumin Ratio (PTAR): An Objective Risk Stratification Tool in Patients with Sepsis.

Authors:  Shaoxiong Wang; Shuizi Ding; Hong Luo; Xiangping Chai
Journal:  Int J Gen Med       Date:  2021-05-12

2.  Incidence, Clinical Characteristics and Outcomes of Early Hyperbilirubinemia in Critically Ill Patients: Insights From the MARS Study.

Authors:  Jenny Juschten; Lieuwe D J Bos; Harm-Jan de Grooth; Ulrich Beuers; Armand R J Girbes; Nicole P Juffermans; Stephan A Loer; Tom van der Poll; Olaf L Cremer; Marc J M Bonten; Marcus J Schultz; Pieter Roel Tuinman
Journal:  Shock       Date:  2022-02-01       Impact factor: 3.454
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.